Evidence map›Paper›PMID 39021070›Full record

ArticlePharmaceutical biology2024

Sabine Kobetitsch, Barbara Gierlikowska, Olaf Kunert, Ahmed M A Mazen, Pia Raab, Nadine Kretschmer, Carina Donolo, Teresa Pirker, Rudolf Bauer, Anna K Kiss and 1 more

Abstract read
In one paragraph

Article in Pharmaceutical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Research Trends and Thematic Evolution ofInternational journal of dentistry · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sabine KobetitschInstitute of Pharmaceutical Sciences, Pharmacognosy, University of Graz, Graz, Austria.
Barbara GierlikowskaDepartment of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Warsaw, Poland.
Olaf KunertInstitute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz, Graz, Austria.
Ahmed M A MazenBotany and Microbiology Department, Faculty of Science, Sohag University, Sohag, Egypt.
Pia RaabInstitute of Pharmaceutical Sciences, Pharmacognosy, University of Graz, Graz, Austria.
Nadine KretschmerInstitute of Pharmaceutical Sciences, Pharmacognosy, University of Graz, Graz, Austria.
Carina DonoloInstitute of Pharmaceutical Sciences, Pharmacognosy, University of Graz, Graz, Austria.
Teresa PirkerInstitute of Pharmaceutical Sciences, Pharmacognosy, University of Graz, Graz, Austria.
Rudolf BauerInstitute of Pharmaceutical Sciences, Pharmacognosy, University of Graz, Graz, Austria.
Anna K KissChair and Department of Pharmaceutical Biology, Medical University of Warsaw, Warsaw, Poland.
Eva-Maria Pferschy-WenzigInstitute of Pharmaceutical Sciences, Pharmacognosy, University of Graz, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextVirtually all parts of

objectiveThis study assesses the oral health-promoting potential of MATERIALS AND

methodsHot-water and methanolic RESULTS AND DISCUSSION: Both extracts showed pronounced anti-inflammatory activity in LPS-stimulated neutrophils. Major identified compound classes were flavonoid glycosides, the glucosinolate glucotropaeolin, phenyl- and benzylglycoside sulfates, and megastigmane glycosylsulfates, the latter ones identified for the first time in

conclusionsGlucotropaeolin and benzylisothiocyanate are likely implicated in the oral health-promoting effects of

Indexed as

Anti-Inflammatory AgentsInflammation MediatorsNeutrophilsPeriodontal DiseasesPlant ExtractsPlant LeavesSalvadoraceaeAnimalsCell Line, TumorCell ProliferationDose-Response Relationship, DrugHumansInterleukin-8MacrophagesMicePhytochemicalsAnti-Inflammatory AgentsInflammation MediatorsInterleukin-8PhytochemicalsPlant ExtractsTumor Necrosis Factor-alphaanti-inflammatoryantiproliferativemegastigmaneToothbrush treeUHPLC-HRMS metabolite profiling

Identifiers

PMID39021070
PMCPMC11259067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.